Generic medicine

Dapagliflozin

Data statusRegistration & price fields require source verification.

15brands/products

3companies

15with current prices

Available dosage forms

Choose a form

Tap a form to filter the brand list

Tablet15 products

Advertisement · clearly labelled sponsored placement

Pakistan brand index

Available brands

15 results

Brand	Manufacturer	Strength	Form	Pack	Reg. no.	Official price	Unit price
Dapatit	Titlis Pharma (Private) Limited	5 mg	Tablet	10's	115200	PKR 1,043.042026-07-23	PKR 104.30/ tablet
Dapatit	Titlis Pharma (Private) Limited	10 mg	Tablet	10's	115201	PKR 1,101.772026-07-23	PKR 110.18/ tablet
Dapatit	Titlis Pharma (Private) Limited	5 mg	Tablet	14's	115200	PKR 1,461.192026-07-23	PKR 104.37/ tablet
Dapatit	Titlis Pharma (Private) Limited	10 mg	Tablet	14's	115201	PKR 1,543.422026-07-23	PKR 110.24/ tablet
Dapwiz	PHARMEVO (PVT) LTD.	10 mg	Tablet	7x4's	107375	PKR 1,886.612025-08-04	PKR 67.38/ tablet
Dapwiz	PHARMEVO (PVT) LTD.	5 mg	Tablet	7x4's	107374	PKR 1,785.562025-08-04	PKR 63.77/ tablet
Dapwiz	PHARMEVO (PVT) LTD.	10 mg	Tablet	14's	107375	PKR 963.152025-08-04	PKR 68.80/ tablet
Dapwiz	PHARMEVO (PVT) LTD.	5 mg	Tablet	10's	107374	PKR 650.892025-08-01	PKR 65.09/ tablet
Dapwiz	PHARMEVO (PVT) LTD.	5 mg	Tablet	7x2's	107374	PKR 911.252025-08-01	PKR 65.09/ tablet
Dapwiz	PHARMEVO (PVT) LTD.	10 mg	Tablet	10's	107375	PKR 687.542025-08-04	PKR 68.75/ tablet
Dapxi	Nabiqasim Industries (Pvt) Ltd.,	10 mg	Tablet	10s	110209	PKR 662.542026-07-23	PKR 66.25/ tablet
Dapxi	Nabiqasim Industries (Pvt) Ltd.,	5 mg	Tablet	14's	110382	PKR 836.772025-08-12	PKR 59.77/ tablet
Dapxi	Nabiqasim Industries (Pvt) Ltd.,	10 mg	Tablet	14's	110209	PKR 883.892025-08-12	PKR 63.14/ tablet
Dapxi	Nabiqasim Industries (Pvt) Ltd.,	5 mg	Tablet	10s	110382	PKR 597.702025-08-12	PKR 59.77/ tablet
Dapxi-Met XR	Nabiqasim Industries (Pvt) Ltd.,	5 mg	Tablet	28's	120012	PKR 2,003.102025-08-12	PKR 71.54/ tablet

Independent editorial layer

Medicine information

Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.